Drug Landscape ›
TTS-fentanyl ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 6
Most-reported reactions
Cachexia — 1 report (16.67%) Hospice Care — 1 report (16.67%) Malaise — 1 report (16.67%) Malignant Neoplasm Progression — 1 report (16.67%) Pain — 1 report (16.67%) Performance Status Decreased — 1 report (16.67%)
Source database →
TTS-fentanyl in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is TTS-fentanyl approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for TTS-fentanyl in United States?
Janssen-Cilag Ltd.,Thailand is the originator. The local marketing authorisation holder may differ — check the official source linked above.